A detailed history of Vivo Capital, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 2,797,704 shares of RZLT stock, worth $12.3 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
2,797,704
Previous 2,797,704 -0.0%
Holding current value
$12.3 Million
Previous $12 Million 12.78%
% of portfolio
1.99%
Previous 1.78%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$0.95 - $2.55 $422,881 - $1.14 Million
-445,138 Reduced 13.73%
2,797,704 $7.13 Million
Q4 2023

Feb 06, 2024

BUY
$0.74 - $1.24 $2.04 Million - $3.42 Million
2,758,403 Added 569.4%
3,242,842 $3.21 Million
Q3 2023

Nov 08, 2023

SELL
$1.32 - $2.1 $6,644 - $10,571
-5,034 Reduced 1.03%
484,439 $639,000
Q2 2022

Aug 15, 2022

BUY
$2.6 - $3.85 $1.27 Million - $1.88 Million
489,473 New
489,473 $1.58 Million

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $171M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.